版本:
中国

BRIEF-Amgen's multiple Myeloma treatment in combination with Dexamethasone, receives NICE recommendation for use at first relapse

June 12 Amgen Inc

* Amgen's multiple Myeloma treatment, Kyprolis® (Carfilzomib), in combination with Dexamethasone, receives NICE recommendation for use at first relapse

* NICE has published its FAD recommending Carfilzomib in combination with Dexamethasone as an option for treating adults with relapsed multiple Myeloma Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐